Loading…

Listeriosis in pediatric oncology patients

BACKGROUND Adult cancer patients are considered to be at an increased risk for Listeria monocytogenes infections, but, to the authors' knowledge, little information regarding this infection in the pediatric oncology population has been published. METHODS The Memorial Sloan‐Kettering Cancer Cent...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1998-08, Vol.83 (4), p.817-820
Main Authors: Mora, Jaume, White, Mary, Dunkel, Ira J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4798-39c4d8eee0d9784535150fe86bdf37ea03ad4d3567a311ce1e659b885b3c18403
container_end_page 820
container_issue 4
container_start_page 817
container_title Cancer
container_volume 83
creator Mora, Jaume
White, Mary
Dunkel, Ira J.
description BACKGROUND Adult cancer patients are considered to be at an increased risk for Listeria monocytogenes infections, but, to the authors' knowledge, little information regarding this infection in the pediatric oncology population has been published. METHODS The Memorial Sloan‐Kettering Cancer Center microbiology laboratory's database was searched for cases of Listeria monocytogenes infection during the period from January 1981 to December 1996, and thorough chart reviews of the cases identified in patients age < 21 years were performed. RESULTS Listerial infections occurred in 5 children (3 with leukemia, 1 with lymphoma, and 1 with a brain tumor) among 20,612 admissions to the pediatric department during this period. All five children were actively receiving therapy for their malignancy, and two also were receiving other potentially immunosuppressive therapies. None was receiving co‐trimoxazole prophylaxis. All were treated successfully for the Listeria monocytogenes infection with ampicillin and gentamicin (four patients) or ampicillin alone (one patient). At last follow‐up two patients were long term, event‐free survivors, two had died of their underlying malignancy, and one patient had died of cytomegalovirus pneumonitis. CONCLUSIONS Listeria monocytogenes infections in pediatric oncology patients can be treated successfully with ampicillin‐containing antibiotic regimens. Cancer 1998;83:817‐820. © 1998 American Cancer Society. Listeria monocytogenes infections historically have been considered to be associated with a high mortality rate in adult cancer patients. This series, which to the authors' knowledge is the first in a pediatric oncology population, indicates that listeriosis may be treated successfully in children with cancer, confirming the better prognosis recently reported in adult oncology patients.
doi_str_mv 10.1002/(SICI)1097-0142(19980815)83:4<817::AID-CNCR28>3.0.CO;2-U
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73862799</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73862799</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4798-39c4d8eee0d9784535150fe86bdf37ea03ad4d3567a311ce1e659b885b3c18403</originalsourceid><addsrcrecordid>eNqFkF2LEzEUhoO4rHXXnyD0QmRXmHoySSZJV8Rl1o9C2YJaWLw5pJkzEpnO1MkU6b93ho69UfAqnJz3vDw8jL3jMOMA6eurL4t8cc3B6gS4TK-4tQYMV9dGzOUbw_V8fru4S_L7_HNq3ooZzPLVTZqsH7HJ6egxmwCASZQUD0_Y0xh_9KNOlThn51aDsYpP2KtliB21oYkhTkM93VERXNcGP21q31TN98N057pAdRcv2VnpqkjPxveCrT-8_5p_Sparj4v8dpl4qa1JhPWyMEQEhdVGKqG4gpJMtilKocmBcIUshMq0E5x74pQpuzFGbYTnRoK4YC-Pvbu2-bmn2OE2RE9V5Wpq9hG1MFmqre2DD8egb5sYWypx14ataw_IAQeNiINGHIzgYAT_aEQjUGKvEbHXiEeNKBAwX2GK6776-ciw32ypOBWP3vr9i3HvondV2brah3iKpSLjoAfCb8fYr1DR4S-8_9L9E278Eb8BgryaUw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73862799</pqid></control><display><type>article</type><title>Listeriosis in pediatric oncology patients</title><source>Wiley</source><source>EZB Free E-Journals</source><creator>Mora, Jaume ; White, Mary ; Dunkel, Ira J.</creator><creatorcontrib>Mora, Jaume ; White, Mary ; Dunkel, Ira J.</creatorcontrib><description>BACKGROUND Adult cancer patients are considered to be at an increased risk for Listeria monocytogenes infections, but, to the authors' knowledge, little information regarding this infection in the pediatric oncology population has been published. METHODS The Memorial Sloan‐Kettering Cancer Center microbiology laboratory's database was searched for cases of Listeria monocytogenes infection during the period from January 1981 to December 1996, and thorough chart reviews of the cases identified in patients age &lt; 21 years were performed. RESULTS Listerial infections occurred in 5 children (3 with leukemia, 1 with lymphoma, and 1 with a brain tumor) among 20,612 admissions to the pediatric department during this period. All five children were actively receiving therapy for their malignancy, and two also were receiving other potentially immunosuppressive therapies. None was receiving co‐trimoxazole prophylaxis. All were treated successfully for the Listeria monocytogenes infection with ampicillin and gentamicin (four patients) or ampicillin alone (one patient). At last follow‐up two patients were long term, event‐free survivors, two had died of their underlying malignancy, and one patient had died of cytomegalovirus pneumonitis. CONCLUSIONS Listeria monocytogenes infections in pediatric oncology patients can be treated successfully with ampicillin‐containing antibiotic regimens. Cancer 1998;83:817‐820. © 1998 American Cancer Society. Listeria monocytogenes infections historically have been considered to be associated with a high mortality rate in adult cancer patients. This series, which to the authors' knowledge is the first in a pediatric oncology population, indicates that listeriosis may be treated successfully in children with cancer, confirming the better prognosis recently reported in adult oncology patients.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/(SICI)1097-0142(19980815)83:4&lt;817::AID-CNCR28&gt;3.0.CO;2-U</identifier><identifier>PMID: 9708951</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Adolescent ; Adult ; ampicillin ; Ampicillin - therapeutic use ; Anti-Bacterial Agents - therapeutic use ; Biological and medical sciences ; Brain Neoplasms - microbiology ; Child ; Drug Therapy, Combination - therapeutic use ; Female ; gentamicin ; Gentamicins - therapeutic use ; Hematologic and hematopoietic diseases ; Humans ; leukemia ; Leukemia - microbiology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Listeria monocytogenes ; Listeriosis - drug therapy ; Listeriosis - etiology ; lymphoma ; Lymphoma, T-Cell - microbiology ; Male ; Medical sciences ; Neoplasms - microbiology ; oligodendroglioma ; pediatric oncology ; Penicillins - therapeutic use</subject><ispartof>Cancer, 1998-08, Vol.83 (4), p.817-820</ispartof><rights>Copyright © 1998 American Cancer Society</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4798-39c4d8eee0d9784535150fe86bdf37ea03ad4d3567a311ce1e659b885b3c18403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2361079$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9708951$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mora, Jaume</creatorcontrib><creatorcontrib>White, Mary</creatorcontrib><creatorcontrib>Dunkel, Ira J.</creatorcontrib><title>Listeriosis in pediatric oncology patients</title><title>Cancer</title><addtitle>Cancer</addtitle><description>BACKGROUND Adult cancer patients are considered to be at an increased risk for Listeria monocytogenes infections, but, to the authors' knowledge, little information regarding this infection in the pediatric oncology population has been published. METHODS The Memorial Sloan‐Kettering Cancer Center microbiology laboratory's database was searched for cases of Listeria monocytogenes infection during the period from January 1981 to December 1996, and thorough chart reviews of the cases identified in patients age &lt; 21 years were performed. RESULTS Listerial infections occurred in 5 children (3 with leukemia, 1 with lymphoma, and 1 with a brain tumor) among 20,612 admissions to the pediatric department during this period. All five children were actively receiving therapy for their malignancy, and two also were receiving other potentially immunosuppressive therapies. None was receiving co‐trimoxazole prophylaxis. All were treated successfully for the Listeria monocytogenes infection with ampicillin and gentamicin (four patients) or ampicillin alone (one patient). At last follow‐up two patients were long term, event‐free survivors, two had died of their underlying malignancy, and one patient had died of cytomegalovirus pneumonitis. CONCLUSIONS Listeria monocytogenes infections in pediatric oncology patients can be treated successfully with ampicillin‐containing antibiotic regimens. Cancer 1998;83:817‐820. © 1998 American Cancer Society. Listeria monocytogenes infections historically have been considered to be associated with a high mortality rate in adult cancer patients. This series, which to the authors' knowledge is the first in a pediatric oncology population, indicates that listeriosis may be treated successfully in children with cancer, confirming the better prognosis recently reported in adult oncology patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>ampicillin</subject><subject>Ampicillin - therapeutic use</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Brain Neoplasms - microbiology</subject><subject>Child</subject><subject>Drug Therapy, Combination - therapeutic use</subject><subject>Female</subject><subject>gentamicin</subject><subject>Gentamicins - therapeutic use</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>leukemia</subject><subject>Leukemia - microbiology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Listeria monocytogenes</subject><subject>Listeriosis - drug therapy</subject><subject>Listeriosis - etiology</subject><subject>lymphoma</subject><subject>Lymphoma, T-Cell - microbiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neoplasms - microbiology</subject><subject>oligodendroglioma</subject><subject>pediatric oncology</subject><subject>Penicillins - therapeutic use</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkF2LEzEUhoO4rHXXnyD0QmRXmHoySSZJV8Rl1o9C2YJaWLw5pJkzEpnO1MkU6b93ho69UfAqnJz3vDw8jL3jMOMA6eurL4t8cc3B6gS4TK-4tQYMV9dGzOUbw_V8fru4S_L7_HNq3ooZzPLVTZqsH7HJ6egxmwCASZQUD0_Y0xh_9KNOlThn51aDsYpP2KtliB21oYkhTkM93VERXNcGP21q31TN98N057pAdRcv2VnpqkjPxveCrT-8_5p_Sparj4v8dpl4qa1JhPWyMEQEhdVGKqG4gpJMtilKocmBcIUshMq0E5x74pQpuzFGbYTnRoK4YC-Pvbu2-bmn2OE2RE9V5Wpq9hG1MFmqre2DD8egb5sYWypx14ataw_IAQeNiINGHIzgYAT_aEQjUGKvEbHXiEeNKBAwX2GK6776-ciw32ypOBWP3vr9i3HvondV2brah3iKpSLjoAfCb8fYr1DR4S-8_9L9E278Eb8BgryaUw</recordid><startdate>19980815</startdate><enddate>19980815</enddate><creator>Mora, Jaume</creator><creator>White, Mary</creator><creator>Dunkel, Ira J.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980815</creationdate><title>Listeriosis in pediatric oncology patients</title><author>Mora, Jaume ; White, Mary ; Dunkel, Ira J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4798-39c4d8eee0d9784535150fe86bdf37ea03ad4d3567a311ce1e659b885b3c18403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>ampicillin</topic><topic>Ampicillin - therapeutic use</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Brain Neoplasms - microbiology</topic><topic>Child</topic><topic>Drug Therapy, Combination - therapeutic use</topic><topic>Female</topic><topic>gentamicin</topic><topic>Gentamicins - therapeutic use</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>leukemia</topic><topic>Leukemia - microbiology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Listeria monocytogenes</topic><topic>Listeriosis - drug therapy</topic><topic>Listeriosis - etiology</topic><topic>lymphoma</topic><topic>Lymphoma, T-Cell - microbiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neoplasms - microbiology</topic><topic>oligodendroglioma</topic><topic>pediatric oncology</topic><topic>Penicillins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mora, Jaume</creatorcontrib><creatorcontrib>White, Mary</creatorcontrib><creatorcontrib>Dunkel, Ira J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mora, Jaume</au><au>White, Mary</au><au>Dunkel, Ira J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Listeriosis in pediatric oncology patients</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1998-08-15</date><risdate>1998</risdate><volume>83</volume><issue>4</issue><spage>817</spage><epage>820</epage><pages>817-820</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>BACKGROUND Adult cancer patients are considered to be at an increased risk for Listeria monocytogenes infections, but, to the authors' knowledge, little information regarding this infection in the pediatric oncology population has been published. METHODS The Memorial Sloan‐Kettering Cancer Center microbiology laboratory's database was searched for cases of Listeria monocytogenes infection during the period from January 1981 to December 1996, and thorough chart reviews of the cases identified in patients age &lt; 21 years were performed. RESULTS Listerial infections occurred in 5 children (3 with leukemia, 1 with lymphoma, and 1 with a brain tumor) among 20,612 admissions to the pediatric department during this period. All five children were actively receiving therapy for their malignancy, and two also were receiving other potentially immunosuppressive therapies. None was receiving co‐trimoxazole prophylaxis. All were treated successfully for the Listeria monocytogenes infection with ampicillin and gentamicin (four patients) or ampicillin alone (one patient). At last follow‐up two patients were long term, event‐free survivors, two had died of their underlying malignancy, and one patient had died of cytomegalovirus pneumonitis. CONCLUSIONS Listeria monocytogenes infections in pediatric oncology patients can be treated successfully with ampicillin‐containing antibiotic regimens. Cancer 1998;83:817‐820. © 1998 American Cancer Society. Listeria monocytogenes infections historically have been considered to be associated with a high mortality rate in adult cancer patients. This series, which to the authors' knowledge is the first in a pediatric oncology population, indicates that listeriosis may be treated successfully in children with cancer, confirming the better prognosis recently reported in adult oncology patients.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>9708951</pmid><doi>10.1002/(SICI)1097-0142(19980815)83:4&lt;817::AID-CNCR28&gt;3.0.CO;2-U</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1998-08, Vol.83 (4), p.817-820
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_73862799
source Wiley; EZB Free E-Journals
subjects Adolescent
Adult
ampicillin
Ampicillin - therapeutic use
Anti-Bacterial Agents - therapeutic use
Biological and medical sciences
Brain Neoplasms - microbiology
Child
Drug Therapy, Combination - therapeutic use
Female
gentamicin
Gentamicins - therapeutic use
Hematologic and hematopoietic diseases
Humans
leukemia
Leukemia - microbiology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Listeria monocytogenes
Listeriosis - drug therapy
Listeriosis - etiology
lymphoma
Lymphoma, T-Cell - microbiology
Male
Medical sciences
Neoplasms - microbiology
oligodendroglioma
pediatric oncology
Penicillins - therapeutic use
title Listeriosis in pediatric oncology patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T02%3A19%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Listeriosis%20in%20pediatric%20oncology%20patients&rft.jtitle=Cancer&rft.au=Mora,%20Jaume&rft.date=1998-08-15&rft.volume=83&rft.issue=4&rft.spage=817&rft.epage=820&rft.pages=817-820&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/(SICI)1097-0142(19980815)83:4%3C817::AID-CNCR28%3E3.0.CO;2-U&rft_dat=%3Cproquest_cross%3E73862799%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4798-39c4d8eee0d9784535150fe86bdf37ea03ad4d3567a311ce1e659b885b3c18403%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73862799&rft_id=info:pmid/9708951&rfr_iscdi=true